Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
---|---|---|---|---|
120110 | Actinomycin D | 50-76-0 | 98% | ![]() |
Actinomycin D is the most significant member of actinomycines, which are a class of p | ||||
120104 | Altiratinib | 1345847-93-9 | 98% | ![]() |
Altiratinib is a novel c-MET/TIE-2/VEGFR inhibitor; effectively reduce tumor burden i | ||||
120103 | AGI-5198 | 1355326-35-0 | 98% | ![]() |
AGI-5198 is a novel R132H-IDH1 inhibitor, identified through a high-throughput screen | ||||
120102 | Acotiamide HCl | 773092-05-0 | 98% | ![]() |
Acotiamide is a drug approved in Japan for the treatment of postprandial fullness, up | ||||
120101 | A66 | 1166227-08-2 | 98% | ![]() |
A66 is a potent and specific p110 inhibitor with IC50 of 32 nM, >100 fold selectiv | ||||
112101 | AV-412 | 451492-95-8 | 99.38% | ![]() |
AV-412 is an EGFR/HER2 inhibitor that binds to and inhibits the epidermal growth fact | ||||
111913 | AR-12 | 742112-33-0 | 98% | ![]() |
AR-12 is an orally available, targeted anti-cancer agent that has been shown in pre-c | ||||
110909 | AR 231453 | 733750-99-7 | 98% | ![]() |
AR231453 is a potent and selective small molecule agonist of GPR119 that enhances glu | ||||
110906 | AZD6738 | 1352226-88-0 | 97% | ![]() |
AZD6738 is an orally available morpholino-pyrimidine-based inhibitor of ataxia telang | ||||
110217 | 3-Amino-2,6-dibromopyridine | 39856-57-0 | 98% | ![]() |
Coming soon! | ||||
110214 | 2-Amino-4-(trifluoromethyl)pyridine | 106447-97-6 | 98% | ![]() |
Coming soon! | ||||
110211 | 1-aminocyclopropanecarboxylic acid | 22059-21-8 | 98% | ![]() |
Coming soon! | ||||
110207 | 3-Amino-1-propanesulfonic acid | 3687-18-1 | 98% | ![]() |
Coming soon! | ||||
102702 | Alda 1 | 349438-38-6 | 98% | ![]() |
Alda 1 is a cell-permeable benzamide compound that selectively enhances the activity | ||||
102619 | ACTB-1003 | 939805-30-8 | 98% | ![]() |
ACTB-1003 is a potent inhibitor of FGFR1 with IC50 <10 nM in FGFR-1 biochemical as | ||||
102613 | ABT-751 | 141430-65-1 | 98% | ![]() |
ABT-751 is a novel bioavailable tubulin-binding and antimitotic sulfonamide agent wit | ||||
102604 | AZD1981 | 802904-66-1 | 98% | ![]() |
AZD1981 is a potent and selective CRTh2 antagonist; displaces radio-labelled PGD2 fro | ||||
101921 | AL 082D06 | 256925-03-8 | 98% | ![]() |
AL 082D06(D-06) is the first selective, nonsteroidal glucocorticoid receptor (GR) ant | ||||
101910 | ANA-12 | 219766-25-3 | 98% | ![]() |
ANA-12 is aTrkB receptor antagonist, which showed direct and selective binding to Trk | ||||
91823 | (3aR,5S)-3a,4,5,7-tetrahydro-5-methyl-3H-pyrano[3,4-c]isoxazole | 1613393-51-3 | 98% | ![]() |
Coming soon! | ||||
91803 | (3aR,5R)-3a,4,5,7-tetrahydro-5-methyl-3H-pyrano[3,4-c]isoxazole | 1220327-45-6 | 98% | ![]() |
Coming soon! | ||||
91411 | Amoxanox | 68302-57-8 | 98% | ![]() |
Amlexanox inhibits mast cell release of allergic mediators, which is also an antialle | ||||
91404 | (3aR,4S,7R,7aS)-Hexahydro-4,7-methanoisobenzofuran-1,3-dione | 14166-28-0 | 98% | ![]() |
The related APILurasidone hydrochlorideThe related intermediates4-(1,2-Benzothiazol-3 | ||||
91401 | (3aR,4S,7R,7aS)-Hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione | 14805-29-9 | 98% | ![]() |
The related APILurasidone hydrochlorideThe related intermediates4-(1,2-Benzothiazol-3 | ||||
901301 | AZD3759 | 1626387-80-1 | ≧99.0% | ![]() |
AZD3759 isan orally available inhibitor of the epidermal growth factor receptor (EGFR | ||||
90702 | 3-(4-Acetoxyphenyl)propanoic acid | 7249-16-3 | 98% | ![]() |
Coming soon! | ||||
90607 | 3-(3-Aminophenyl)propanoic acid | 1664-54-6 | 98% | ![]() |
Coming soon! | ||||
90102 | 3-Azetidinecarboxylic Acid | 36476-78-5 | 98% | ![]() |
Coming soon! | ||||
83110 | 1-aminocyclohexane-1-carboxylic acid | 2756-85-6 | 98% | ![]() |
Coming soon! | ||||
83109 | 2-amino-2-ethylbutanoic acid | 2566-29-2 | 98% | ![]() |
Coming soon! |
Overnight Delivery
Fast & Safe Delivery Worldwide
Safety and Security
Intimate Service
Copyright 2015-2025 Wuhan Sun-shine Bio-technology Corporation Limited. | 鄂ICP备17005301号-1